iTeos Therapeutics Inc.

ITOS | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.15

+$0.02 (+0.20%)

At close: Aug 29, 2025, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $448.68M

Enterprise Value $-61.62M

Beta 1.49

Average Volume N/A

Shares Outstanding (Diluted) 43.56M

Shares Change YoY 9.74%

Institutional Ownership 84.47%

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -1.1%

1Y CAGR (ann.) -41.5%

5Y CAGR (ann.) -19.5%

All-Time CAGR -11.6%

Valuation

PE Ratio -2.14

Forward PE N/A

PEG Ratio 0.07

Forward PEG -0.05

PS Ratio N/A

Forward PS 5.90

PB Ratio 0.91

P/FCF Ratio -4.13

P/Adj. FCF Ratio -3.30

P/OCF Ratio -5.80

EV/Sales N/A

EV/EBIT 0.31

EV/EBITDA 0.31

EV/FCF 0.57

Earnings Yield -46.7%

FCF Yield -24.2%

Adj. FCF Yield -30.3%

Financial Health

Net Cash $515.43M

Total Debt $5.13M

Cash & Short-Term Investments $515.43M

Total Assets $623.08M

Current Ratio 7.53

Quick Ratio 7.53

Debt / Equity Ratio 0.01

Debt / EBITDA -0.03

Debt / FCF -0.05

OCF / Debt -21.07

Interest Coverage 0.00

Altman Z-Score 1.65

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -25.0%

Returns

Return on Assets -18.2%

Return on Equity -21.4%

Return on Invested Capital -22.3%

Return on Capital Employed -22.4%

Return on Tangible Assets -18.2%

Historical Growth (CAGR)

Revenue CAGR 3Y -117.6%

Revenue CAGR 5Y -39.7%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -68.4%

EPS CAGR 5Y -412.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y 2.3%

FCF CAGR 5Y -360.4%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 8

EPS Growth Next 3Y 10.4%

Revenue Growth Next 3Y N/A

Earnings Date Aug 5, 2025

EPS Estimate (next Q) -$1.12

EPS Growth Est (next Q) 522.2%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $18.20

Price Target Upside 79.3%

Cash Flow

Operating Cash Flow $-108.06M

Free Cash Flow $-108.69M

Adj. Free Cash Flow $-135.83M

FCF Per Share -$1.76

OCF Per Share -$1.75

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-35.01M

Operating Income $-221.94M

EBITDA $-201.67M

Net Income $-202.41M

EPS (Diluted) -$4.74

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A